Category Archives: Prescribing Newsletter

Valproate Pregnancy Prevention Programme

The MHRA has determined that valproate medicines should now be contraindicated in women & girls of childbearing potential unless the conditions of a new Pregnancy Prevention Programme are met. The April 2018 edition of the MHRA Drug Safety Update includes the following advice for healthcare professionals: GPs must identify and recall all women and girls who may be Continue Reading »

MHRA Warning – Watch out for look-alikes & sound-alikes

The MHRA have recently highlighted the dangers associated with medicines with look-alike or sound-alike names – including cases with fatal outcomes, in which patients received the wrong medicine due to confusion between similar names. Drugs pairs known to have been linked to errors include: Clobazam / Clonazepam; Atenolol / Amlodipine; Propranolol / Prednisolone; Risperidone / Ropinirole; Sulfadiazine / Sulfasalazine and Continue Reading »

Unblocking EPS2

Are you struggling to send some prescriptions by EPS2? The NHS Dictionary of Medicines and Devices (dm+d) is the standard for transferring medicine and medical device information between clinical systems and is required for all EPS2 prescribing. Some entries in the prescribing databases used by GP clinical systems cannot be directly matched to a unique dm+d code – Continue Reading »